Finanzwire Finanzwire
Basculer en Français
10820 Companies
234662 Keywords
163521 Articles
125583 Press releases
Headlines Articles Press releases Bio-Gate AG Remove
  1. Home
  2. Companies
  3. Bio-Gate AG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 07/20/2026 at 19:21, 22 days 11 hours ago

    Bio-Gate AG Announces Capital Increase Proposal

    Shareholders Investment Strategy Capital Increase Financial Flexibility Rights Offering
  • PRESS RELEASE

    published on 07/20/2026 at 19:16, 22 days 12 hours ago

    EQS-Adhoc: Bio-Gate AG: Resolves to Conduct a Capital Increase from Authorized Capital and Announces the Terms of the Rights Offering Approved by the Annual General Meeting on June 30, 2026

    Bio-Gate AG resolves to conduct a capital increase from authorized capital and announces terms of rights offering, aiming to strengthen financial flexibility and implement growth strategy efficiently
    Capital Increase Authorized Capital Financial Flexibility Rights Offering Bio-Gate AG
    Logo of Bio-Gate AG
  • PRESS RELEASE

    published on 07/31/2023 at 17:01, 3 years ago

    Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants

    Logo of Bio-Gate AG
Accesswire
  • Published on 08/12/2026 at 00:00, 7 hours 20 minutes ago

    Organto Foods Reports Record Second Quarter 2026 Financial Results

  • Published on 08/11/2026 at 23:40, 7 hours 40 minutes ago

    RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000

  • Published on 08/11/2026 at 23:15, 8 hours 5 minutes ago

    Fermi and Hillcore Energy Capital Announce 2.6 Gigawatt Power Strategic Alliance for Project Matador

  • Published on 08/11/2026 at 23:00, 8 hours 20 minutes ago

    Prospectiva Resources Ltd. Completes Qualifying Transaction

  • Published on 08/11/2026 at 22:55, 8 hours 25 minutes ago

    NV Gold Announces Non-Brokered Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 08/12/2026 at 07:00, 19 minutes ago

    MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor

  • Published on 08/12/2026 at 07:00, 19 minutes ago

    SCHOTT Pharma with strong third quarter and on track for planned growth

  • Published on 08/12/2026 at 07:00, 19 minutes ago

    TUI delivered resilient Q3 underlying EBIT of €234.6m (at CC), demonstrating the strength of its business despite geopolitical headwinds and one-offs, FY26 guidance reaffirmed

  • Published on 08/12/2026 at 07:00, 19 minutes ago

    E.ON remains on track and continues to invest in the energy transition

  • Published on 08/12/2026 at 07:00, 19 minutes ago

    Subdued demand weighs on Hawesko's business in the first half of the year – gross profit margin up – cost and efficiency progress taking effect – full-year 2026 guidance adjusted

View all EQS
Les Echos
  • Published on 08/10/2026 at 18:00, 1 day 13 hours ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

  • Published on 08/10/2026 at 17:45, 1 day 13 hours ago

    Weekly share buyback

  • Published on 08/10/2026 at 11:53, 1 day 19 hours ago

    GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

  • Published on 08/10/2026 at 11:36, 1 day 19 hours ago

    GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026

  • Published on 08/10/2026 at 09:22, 1 day 21 hours ago

    Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy